The role of pharmacists in eliminating counterfeit medicines in Nigeria

The role of pharmacists in eliminating counterfeit medicines in Nigeria

IntroductionOver the years, counterfeit pharmaceuticals have posed immense concerns for global health and patient safety. This menace encompasses various classes of medications. Given the criticality of pharmacists’ interventions in drug distribution and supply, this study aimed at exploring their r...

Full description

Bibliographic Details
Main Author:	Obi Peter Adigwe
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Public Health
Subjects:	substandard pharmaceuticals healthcare drugs products falsified
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2023.1170929/full

Similar Items

Pharmacists’ perceptions and attitudes toward drug importation into the State of Florida
by: John B. Hertig, et al.
Published: (2021-12-01)

Global scenario of counterfeit antimalarials: A potential threat
by: Taruna Arora, et al.
Published: (2019-01-01)

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
by: Daariimaa Khurelbat, et al.
Published: (2020-05-01)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
by: Yusuf Hassan Wada, et al.
Published: (2022-06-01)

Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
by: Kah Seng Lee, et al.
Published: (2017-05-01)

Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations
by: Huma Rasheed, et al.
Published: (2019-12-01)

Medicine recalls in Saudi Arabia: a retrospective review of drug alerts (January 2010–January 2019)
by: Bushra T. AlQuadeib, et al.
Published: (2020-11-01)

Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries
by: Lukas Roth, et al.
Published: (2018-04-01)

Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020-03-01)

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
by: Kathryn D. Jackson, et al.
Published: (2020-07-01)

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems
by: Lukas Roth, et al.
Published: (2018-11-01)

Evaluation of Seven Different Brands of Metformin Hydrochloride Tablets Available in the Market in Gondar City, Ethiopia
by: Flatie Alemu A, et al.
Published: (2024-02-01)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
by: Waleed M. Sweileh
Published: (2021-09-01)

Post marketing surveillance of selected veterinary medicines in Tanzania mainland
by: Adam M. Fimbo, et al.
Published: (2022-06-01)

Verification of the active pharmaceutical ingredient in tablets using a low-cost near-infrared spectrometer
by: Julia Gabel, et al.
Published: (2023-12-01)

“It is very difficult in this business if you want to have a good conscience”: pharmaceutical governance and on-the-ground ethical labour in Ghana
by: Kate Hampshire, et al.
Published: (2022-12-01)

Fake anabolic androgenic steroids on the black market – a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature
by: Raphael Magnolini, et al.
Published: (2022-07-01)

Tackling the blind spot of poor-quality medicines in Universal Health Coverage
by: E. S. F. Orubu, et al.
Published: (2020-12-01)

Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study
by: Kevin Pozsgai, et al.
Published: (2022-09-01)

The rise of counterfeit medication: an emerging threat?
by: Muhammad Omar Larik
Published: (2024-01-01)

The rise of counterfeit medication: an emerging threat?
by: Muhammad Omar Larik
Published: (2024-01-01)

I (Don’t) want to consume counterfeit medicines: exploratory study on the antecedents of consumer attitudes toward counterfeit medicines
by: Sylvester Senyo Ofori-Parku, et al.
Published: (2022-06-01)

The capacity of young national medicine regulatory authorities to ensure the quality of medicines: case of Rwanda
by: Jean Baptiste B. Shabani, et al.
Published: (2022-12-01)

Exploring pharmacists' perspectives about substandard and falsified medical products through interviews
by: A. Persson, et al.
Published: (2024-03-01)

Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community
by: Stanislav Kniazkov, et al.
Published: (2020-12-01)

Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review
by: Kari A. Griffore, et al.
Published: (2023-11-01)

A blockchain based medicine production and distribution framework to prevent medicine counterfeit
by: Iyolita Islam, et al.
Published: (2024-01-01)

Quality of selected anti-retroviral medicines: Tanzania Mainland market as a case study
by: Sophia Mziray, et al.
Published: (2021-08-01)

Quality, availability and storage conditions of oxytocin and misoprostol in Malawi
by: Nhomsai Hagen, et al.
Published: (2020-03-01)

Time to Invest in Medicines Resilience
by: Ravina Barrett
Published: (2021-02-01)

THE IMPACT OF THE EUROPEAN DIRECTIVE AGAINST FALSIFIED MEDICINES ON THE PHARMACEUTICAL WHOLESALERS IN BULGARIA
by: Krasimira Valcheva
Published: (2021-03-01)

Serialization and Verification of Medicinal Products – A Pilot Study Among Pharmacists in Bulgaria
by: Nedelkov N., et al.
Published: (2019-10-01)

Falsified drugs as a challenge to public health - an attempt to define the concept and scale of the phenomenon in the world as well as legal and sociological approach
by: Damian Świeczkowski, et al.
Published: (2019-12-01)

Counterfeit and substandard drugs in Tanzania: A review
by: Petro Karungamye
Published: (2023-07-01)

An exploratory assessment of the legislative framework for combating counterfeit medicines in South Africa
by: R. J. Moshoeshoe, et al.
Published: (2022-12-01)

Reports of substandard medicines: a lexicographic analysis of the Brazilian Health Surveillance Report System
by: Mayra Bruna Fedalto, et al.
Published: (2021-12-01)

Quality of dorzolamide hydrochloride and timolol maleate containing eye drops distributed online
by: Sára Merczel, et al.
Published: (2023-06-01)

The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines
by: Marija Anđelković, et al.
Published: (2017-06-01)

Commentary: Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
by: Baobin Huang, et al.
Published: (2017-12-01)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
by: Robin Rojas-Cortés
Published: (2020-10-01)